Witnessing the stock’s movement on the chart, on April 30, 2021, Teva Pharmaceutical Industries Limited (NYSE: TEVA) set off with pace as it heaved 0.56% to $10.70. During the day, the stock rose to $10.73 and sunk to $10.45 before settling in for the price of $10.64 at the close. Taking a more long-term approach, TEVA posted a 52-week range of $8.44-$13.30.
It was noted that the giant of the Healthcare sector posted annual sales growth of -3.30% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -32.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -297.90%. This publicly-traded company’s shares outstanding now amounts to $1.10 billion, simultaneously with a float of $1.09 billion. The organization now has a market capitalization sitting at $11.48 billion. At the time of writing, stock’s 50-day Moving Average stood at $10.96, while the 200-day Moving Average is $10.49.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 39717 workers. It has generated 1,442,475 per worker during the last fiscal year. Meanwhile, its income per employee was -345,488. The stock had 3.34 Receivables turnover and 0.32 Total Asset turnover. For the Profitability, stocks gross margin was +46.38, operating margin was +18.36 and Pretax Margin of -26.45.
Teva Pharmaceutical Industries Limited (TEVA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Teva Pharmaceutical Industries Limited’s current insider ownership accounts for 0.78%, in contrast to 52.60% institutional ownership. According to the most recent insider trade that took place on Mar 16, this organization’s See “Remarks” below sold 127,244 shares at the rate of 11.22, making the entire transaction reach 1,427,614 in total value, affecting insider ownership by 20,598. Preceding that transaction, on Mar 05, Company’s EVP, North America Commercial sold 11,436 for 10.54, making the whole transaction’s value amount to 120,580. This particular insider is now the holder of 14,868 in total.
Teva Pharmaceutical Industries Limited (TEVA) Earnings and Revenue Records
As on 3/30/2021, Multinational firm has announced its last quarter scores, in which it reported $0.63 earnings per share (EPS) for the period topping the consensus outlook (set at $0.59) by $0.04. This company achieved a net margin of -23.95 while generating a return on equity of -34.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.67 per share during the current fiscal year.
Teva Pharmaceutical Industries Limited’s EPS decrease for this current 12-month fiscal period is -297.90% and is forecasted to reach 2.75 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 5.77% through the next 5 years, which can be compared against the -32.00% growth it accomplished over the previous five years trading on the market.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Trading Performance Indicators
Let’s observe the current performance indicators for Teva Pharmaceutical Industries Limited (TEVA). It’s Quick Ratio in the last reported quarter now stands at 0.70. The Stock has managed to achieve an average true range (ATR) of 0.34. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.71.
In the same vein, TEVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.63, a figure that is expected to reach 0.59 in the next quarter, and analysts are predicting that it will be 2.75 at the market close of one year from today.
Technical Analysis of Teva Pharmaceutical Industries Limited (TEVA)
Going through the that latest performance of [Teva Pharmaceutical Industries Limited, TEVA]. Its last 5-days volume of 11.74 million indicated improvement to the volume of 9.56 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 65.44% While, its Average True Range was 0.35.
Raw Stochastic average of Teva Pharmaceutical Industries Limited (TEVA) in the period of the previous 100 days is set at 32.82%, which indicates a major fall in contrast to 63.79% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 37.61% that was lower than 42.93% volatility it exhibited in the past 100-days period.